The Middle Eastern stock markets have recently experienced mixed performance, with Saudi Arabia and Abu Dhabi facing downward pressure due to lackluster earnings, while Dubai has shown resilience with gains driven by strong corporate results. In such a fluctuating environment, identifying promising investment opportunities requires a keen eye for companies with solid fundamentals. Penny stocks, though an older term, still signify smaller or emerging companies that can offer significant value and growth potential when backed by strong financials.
Name
Share Price
Market Cap
Financial Health Rating
Big Tech 50 R&D-Limited Partnership (TASE:BIGT)
₪1.391
₪14.76M
★★★★★★
Thob Al Aseel (SASE:4012)
SAR3.89
SAR1.56B
★★★★★★
Alarum Technologies (TASE:ALAR)
₪4.173
₪294.79M
★★★★★★
Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi (IBSE:MEGAP)
TRY4.75
TRY1.31B
★★★★★☆
E7 Group PJSC (ADX:E7)
AED1.55
AED3.1B
★★★★★★
Al Wathba National Insurance Company PJSC (ADX:AWNIC)
AED3.27
AED676.89M
★★★★★☆
Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR)
AED3.30
AED381.15M
★★★★★★
Dubai Investments PJSC (DFM:DIC)
AED2.96
AED12.63B
★★★★☆☆
Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)
AED0.787
AED480.52M
★★★★★★
Tgi Infrastructures (TASE:TGI)
₪2.594
₪192.84M
★★★★★★
Click here to see the full list of 77 stocks from our Middle Eastern Penny Stocks screener.
Let’s review some notable picks from our screened stocks.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: United Arab Bank P.J.S.C. offers commercial banking products and services to institutional and corporate clients in the United Arab Emirates, with a market capitalization of AED 2.48 billion.
Operations: The company’s revenue is derived from three main segments: Retail Banking (AED 74.79 million), Wholesale Banking (AED 468.96 million), and Treasury and Capital Markets (AED 209.62 million).
Market Cap: AED2.48B
United Arab Bank P.J.S.C. presents a compelling case for investors interested in penny stocks, with a market capitalization of AED 2.48 billion and diverse revenue streams across retail, wholesale banking, and treasury markets. The bank’s Price-To-Earnings ratio (6.7x) is attractively below the AE market average, suggesting potential value. Recent earnings reports indicate strong growth, with net income rising to AED 106.18 million in Q2 2025 from AED 70.27 million the previous year. Despite high bad loans (2.2%), UAB maintains an appropriate Loans to Deposits ratio (75%) and stable weekly volatility (6%).
ADX:UAB Financial Position Analysis as at Jul 2025
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Union Insurance Company P.J.S.C. provides insurance products across the United Arab Emirates, Gulf Cooperation Council, and international markets with a market cap of AED229.99 million.
Operations: The company’s revenue is derived from two main segments: Life Insurance, which generated AED16.83 million, and General Insurance, contributing AED246.91 million.
Market Cap: AED230M
Union Insurance Company P.J.S.C. stands out in the penny stock arena with a market cap of AED229.99 million and a focus on life and general insurance, generating AED263.74 million in revenue. The company has recently become profitable, reporting Q1 2025 net income of AED13.05 million, up from AED11.78 million the previous year, despite low Return on Equity at 15.4%. With no debt and a Price-To-Earnings ratio of 5.8x below the AE market average, it offers potential value but is impacted by large one-off gains (AED14.2M) affecting earnings quality and faces challenges covering long-term liabilities with short-term assets (AED737.9M).
ADX:UNION Financial Position Analysis as at Jul 2025
Simply Wall St Financial Health Rating: ★★★★★★
Overview: PlantArc Bio Ltd. is an Ag-Bio company focused on crop protection and yield enhancement, with a market cap of ₪6.63 million.
Operations: The company generates revenue from its Agricultural Biotech segment, amounting to ₪4.40 million.
Market Cap: ₪6.63M
PlantArc Bio Ltd., with a market cap of ₪6.63 million, operates in the Ag-Bio sector focusing on crop protection and yield enhancement. The company is pre-revenue, generating only ₪4.40 million from its Agricultural Biotech segment, which is not considered significant revenue. Despite being unprofitable, PlantArc Bio has no debt and boasts a cash runway exceeding three years based on current free cash flow trends. Its management team and board are experienced with average tenures of 4.8 and 4.3 years respectively, although the stock price remains highly volatile compared to most IL stocks over recent months.
TASE:PLNT Debt to Equity History and Analysis as at Jul 2025
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ADX:UAB ADX:UNION and TASE:PLNT.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
